RE:Beware of more BSTOP Broker -- if you actually even are a licensed broker anywhere, you came on this site last year claiming to be helping a friend make a decision on PMN.
Since then , based on your comments, we first hear you have no interest in the company , then you actually admit you have a very little position in the company, then you wont be recommending the company to anyone, then this year you comment that the company is about to break out , then you have suggetions how to remove the board and executive, then recently you again comment that if things stay the way they are you (and in one case say "we") cannot recommend the company to clients.
I have a number of freinds that are financial and investment advisors, and the first thing they all tell me, they cannot recommend or invest their clients money in any stocks under $1.00 . So why is it that you as a big time New York Broker, would even consider recommending a penny stock that is only trading on the OTC in the USA. I am starting to think that you are full of frozen pond hockey pucks. COME CLEAN with who you actually are and whats your real motive. Some of your previous posts are listed below. Moist important make sure you get out and vote for the next president.
______________________________________________________________________
top brokers posts over the last year on Stockhouse
8 October 2020 - My Comments
I do not generally keep reviewing a penny stock with questionable management, but some shareholders of this biotech have asked. The sign things were gone side ways was when your Directors granted themselves an enormous compensation package with no achievments . I continue to not recommend this Company till i see a new President and Chairman and a board overhaul. All i have ever seen from this Company is an orchestrated price manipulation, followed by financings that distort your value. We will defer from recommending this stock.
_____________________________________________________________________
18 December 2019- RE:RE:Objective analysis
I have no motive and have told my friend that I would let h know what the investment community would look at and the interpretation of those findings. You can certainly make your own decisions, but investment brokers have a fiduciary responsibility to protect their clients and to advise of any irregularities they uncover and this company has many. I am not disputing their possible scientific suggestions, but rather their continuous misinformation and corporate governance. One at the present time is their financing plan, hugely discriminate to long term shareholders and their timing is something I frankly would suggest is done by someone who lacks the knowledge of the equity markets. Yes you certainly can wave their corporate flag, but the proof is they have failed in so many areas. Good Luck.
18 December 2019- RE:RE:RE:RE:Objective analysis
I guess the truth is offensive to sum. Firstly I did not say to sell any shares as was stated by a previous poster O was asked to share the perspective of what I see is the problem with this Company, you can choose to accept it or not, I really could care less. The proof which many refuse to accept I understand, when you see your investment going nowhere you only have hope to hang on to. But in reality if mistakes are not addressed they seem to continue.
28 December 2019- RE:RE:RE:RE:RE:RE:RE:Directors review
I hope for your sake and my friend a very large shareholder. I unfortunately do not have the luxury of being hypothetical and have to analyze people's past performance and present actions. If in fact this happens I can tell you the main catalyst is your Dr. Cashman and Plotkin, not the dead weight Directors you have on your board. I never disputed the science and right now the majors are not climbing all over this to do a deal on any of your neurological Developments. Lots of talk, money spent and shareholder worth eroded. If anything you can learn from Yale it is to look at the entire picture, not just what you want to see.
14 Janaury 2020- Conference Feedback
Not that I have much of a position in PMN, there has been some very positive comments made from some of the large pharmaceutical representatives pertaining to toxic oligomers and PMN. It appears that they are impressed with PMNs representatives. It appears to be getting on some brokers radar screen and warrants a closer look.
12 February 2020- NO Market
If you ever want this Company to be recognized then you need broker participation and your Directors need to know this. Doctors are great , but the market needs a drummer, not a violin. I follow the American exchange for obvious reasons and 2k volume is not a market.
29 March 2020- Poor Judgement
Your Company needs to focus on medical achievements and getting Pharmaceutical Giants interested in the new scientic findings. Any fool can ask for a repricing of warrants and doing so when the North American financial sector is in chaos is the wrong signal to investors. In my opinion you need to ask who is making these inappropriate decisions at a time people are in financial distress. In my due dilligence of your company I found from sources that your management team had offers to collaborate your alzheimers antibody and they refused. Let me tell you the bone yard is full of pompous Directors that refuse to negotiate on behalf of its shareholders because they believe they are the smartest in the room, if that is the case then why has Big Pharma not been convinced of that. Lots of questions to ask and there seems to be a concerted effort to not tell the truth. But hey what do I know, I just told my clients not to buy at the 20 cent level.
1 May 2020-
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PMN creates novel intrabodies for ALS, fron
You are absolutely correct M101 and will probably feel the wrath of those Sunday investors. This management team has constantly made bad decisions on finance and even now trying to get the stock price up after you repriced 66 million warrants, ridiculous. Your board of appointed lap dogs do nothing to encourage anyone to invest in this company. You need a board overhaul and get rid of dead weight, Roth, Kirwin,Wyman,Geffken, Blacher and Giovinazzo are all dead weight Directors and do nothing to enhance shareholder value. In fact they are a detriment to this Company. At the next AGM send a strong message to your duo that you will not tolerate anymore poor business decisions. If you want we have lots of good Lawyers in NewYork i can recommend to set this Company up in a more acceptable shareholder manner.
25 May 2020- Time is right
If what my Boston connections tell me are true and I have no doubt, you are about to see this little Biotech skyrocket.
25 May 2020 - RE:RE:Time is right
My clients do. You just need to make sure this CEO of yours does not do a cheap financing when good news comes. I will prepare a list of Directors I think you all should withhold your votes at the next AGM.
27 May 2020- Promis Analysis
You are correct for the first time, I do not invest in penny stocks and am a deivative specialist. So for you who do not know what that entails, here is an example. Buy 100,000 shares of Merck and sell the September 18, $75.00 calls, net return to investor 11%. Constant returns is where the big money stays. I have one person who asked me to do an analysis on this little Biotech and i see this is a very useless board and weak management team. Your only saving grace will be your Chief Doctor who seems to have hit the correct scientific sequence. Your Company is froth with redundant Directors as i previously mentioned. Like it or not I really do not care.
17 June 2020- Called it Right
In this business reputation means everything. Now for the investment challenged individuals, ask who would benefit from having a high affinity to the worlds best serology test. If this eludes you then you really need someone to manage your money and do not get me wrong, I am not looking for clients.
2 September 2020- My Comments
I have been asked to comment about this Company and why it never gets any attention in the marketplace, that is an easy question, NO CONFIDENCE IN MANAGEMENT. Your Directors have not done anything to create shareholder appreciation but have increased their own by taking salaries that are quite frankly bordering on criminal. The old adage, TALK IS CHEAP!!!!!!!